# Harris Teeter is rolling out expanded GLP-1 medication options alongside nutrition support services.

*business · news · 2026-05-01 · Benzinga*

## Key points

- Harris Teeter is expanding GLP-1 medication options with pharmacist and dietitian support services.
- Kroger's EPS and revenue estimates have increased, reflecting optimism about new wellness initiatives.
- Kroger is trading at a premium with a P/E of 44.2x, indicating a steep valuation against peers.
- Recent analyst target price upgrades range from $71 to $83, highlighting anticipated upside potential.
- Kroger's performance slightly outpaces its sector despite a 5.69% annual decline in stock price.

**Companies:** Kroger
**Countries:** United States

[Read the full story on Benzinga](https://www.benzinga.com/markets/equities/26/05/52211299/kroger-expands-glp-1-medications-nutrition-support)

---

Canonical: https://newsio.io/n/b58a315d-4df3-4871-9077-2867d607a29f/harris-teeter-is-rolling-out-expanded-glp-1-medication-options-alongside-nutriti
Summarized by Newsio from Benzinga. https://newsio.io/how-it-works